| ???? |
2-Deoxy-2,2-difluoro-D-erythro pentonic acid gamma-lactone 3,5-dibenzoate |
| ?? ?? |
2-Deoxy-2,2-difluoro-D-erythro pentonic acid gamma-lactone 3,5-dibenzoate; 2-Deoxy-2,2-difluoro-D-erythro-pentonic acid gamma-lactone 3,5-dibenzoate; 2-Deoxy-2,2-difuoro-D-Ribofuranofuranose-3,5-dibenzoate; 3,5-Di-O-benzoyl-2-deoxy-2,2-difluoro-D-erythropentane-1,4-lactone; Intermediate of Capecitabine; capecitabine intermediate; 2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate; 2-Deoxy-2,2-difluoropentofuranos-1-ulose-3,5-dibenzoate; 2-Deoxy-2,2-difluoro-D-erythro-pentofuranous-1-ulose-3,5- dibenzoate; 2-Deoxy-2,2-difluoro-D-erythro-pentofuranos-1-ulose-3,5-dibenzoate; 3,5-Di-O-benzoyl-2-deoxy-2,2-difluoro-D- erythropentane-1,4-lactone; 4,4-difluoro-5-oxo-2-{[(phenylcarbonyl)oxy]methyl}tetrahydrofuran-3-yl benzoate (non-preferred name); 2'-Deoxy-2',2',-difluoro-D-erythro-pentofuranous-1-ulose-3,5-dibenzoate; 2'-Deoxy-2',2'-difluoro-D-erythro-pentofuranous-1-ulose-3,5-dibenzoate; T6; 2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate; 2-Deoxy-2,2-difluoro-D-erythro-pentofuranous-1-ulose-3,5-dibenzoate; 4,4-difluoro-2-((3-fluorobenzoyloxy)methyl)-5-(methylsulfonyloxy)tetrahydrofuran-3-yl 3-fluorobenzoate; 3,5-Di-O-benzoyl-2-deoxy-2,2-difluoro-D-ribofuran-1-ulose; T6:2-deoxy-2,2-difluoro-D-erythro-pentofuranos-1-ulose-3,5-dibenzoate |
| ??? |
C19H14F2O6 |
| ??? |
376.3077 |
| InChI |
InChI=1/C19H14F2O6/c20-19(21)15(27-17(23)13-9-5-2-6-10-13)14(26-18(19)24)11-25-16(22)12-7-3-1-4-8-12/h1-10,14-15H,11H2 |
| cas?? |
122111-01-7 |
| ?? ?? |
|
| ?? |
1.41g/cm3 |
| ??? |
437.2°C at 760 mmHg |
| ?? ?? |
1.57 |
| ??? |
210.5°C |
| ??? |
7.61E-08mmHg at 25°C |
| ??? ?? |
|
| ??? ?? |
|
| ?? ?? |
|
|
KR
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IL
IN
IR
IT
JP
MY
NL
NO
PL
PT
RU
SA
TR
